Prognostic Value of Circulating Tumor Cell Characteristics May Be Biased by Their Quantity

J Clin Oncol. 2022 Feb 10;40(5):519-520. doi: 10.1200/JCO.21.01959. Epub 2021 Dec 8.

Authors

Manouk K Bos¹, Jaco Kraan¹, Stefan Sleijfer¹, John W M Martens¹, Nick Beije¹

Affiliation

¹ Manouk K. Bos, MD, Jaco Kraan, PhD, Stefan Sleijfer, MD, PhD, John W. M. Martens, PhD, and Nick Beije, MD, PhD, Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

PMID: 34878805
DOI: 10.1200/JCO.21.01959

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor
Humans
Neoplastic Cells, Circulating*
Prognosis

Substances

Biomarkers, Tumor